mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.008 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.009 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.009 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |